ClinicalTrials.Veeva

Menu

Soy Protein in Early Diabetic Nephropathy

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 2
Phase 1

Conditions

Diabetic Nephropathy
Diabetes Mellitus

Treatments

Drug: soy protein

Study type

Interventional

Funder types

NIH

Identifiers

NCT00067678
R21AT000323-01

Details and patient eligibility

About

Diabetic nephropathy is a frequent cause of end-stage renal disease. Reduction of dietary protein has been used to slow down renal disease progression, but patients are often unwilling to make these dietary changes. Other research suggests that changing the quality of dietary protein may be as effective as reducing the total amount of ingested protein. This study hopes to show that soy protein, a plant protein relatively high in essential amino acids and with high nutritional value, maye be beneficial to Type I diabetic patients with incipient renal disease.

Sex

All

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

  • Age 18-40;
  • Diabetic nephropathy;
  • Type I diabetes mellitus.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems